FDA Approves Dosage of Pancreatic Enzyme Supplement ZENPEP for Infants
Originally posted in Cystic Fibrosis Foundation
Originally posted in Cystic Fibrosis Foundation
Jun
17
2011
17
2011
Jun
17
2011
17
2011
Jun
17
2011
17
2011
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study With Inhaled Liposomal Ciprofloxacin
Originally posted in Cystic Fibrosis News From Medical News Today
Aradigm Corporation (OTCBB:ARDM) (the “Company”) today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory Bronchiectasis Inhalation Treatment – ORBIT-1) with Aradigm’s ciprofloxacin for inhalation (CFI, ARD-3100, LipoquinTM) in patients with non-cystic fibrosis bronchiectasis (BE)…
by Raelene
